Form 485BPOS T. Rowe Price Equity
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260424/AMZZ7G2CZ22TLZJZ2P2S2ZZ2CVPOZZ2SZX82
Filed on: April 24, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
- EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
- PSQ Holdings Announces Second Quarter 2026 Financial Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
